Clinical Trial Update: SynCardia CardioWest TAH-t Postmarket Surveillance Study

View source ↗

Summary

The postmarket surveillance study of the CardioWest Total Artificial Heart (TAH-t) for biventricular failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biventricular Failure

Drugs mentioned

• CardioWest Total Artificial Heart (TAH-t)

Snippet

Sponsor: SynCardia Systems. LLC | Conditions: Biventricular Failure | Status: COMPLETED